Effects of the combination of anti-PcrV antibody and bacteriophage therapy in a mouse model of Pseudomonas aeruginosa pneumonia
ABSTRACT Acute lung injury caused by Pseudomonas aeruginosa is attributed to the translocation of cytotoxin into pulmonary epithelial cells via the P. aeruginosa type III secretion system. This virulence can be blocked with a specific antibody against PcrV in this secretion system. However, because...
Saved in:
| Main Authors: | Ohara Junya, Fujiki Jumpei, Mao Kinoshita, Kazuki Sudo, Ken Kawaguchi, Keita Inoue, Yoshifumi Naito, Kiyoshi Moriyama, Tomohiro Nakamura, Hidetomo Iwano, Teiji Sawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2024-12-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.01781-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fc-modification of anti-PcrV gene-encoded antibodies modulates complement-mediated killing of Pseudomonas aeruginosa
by: Jillian Eisenhauer, et al.
Published: (2025-07-01) -
Bacteriophages against Salmonella enterica: challenges and opportunities
by: Nalleyt Segundo-Arizmendi, et al.
Published: (2025-08-01) -
Comparative evaluation of long-term preservation methods for morphologically distinct bacteriophages
by: Wanqi Huang, et al.
Published: (2025-07-01) -
Personalized therapy with bacteriophages of digestive diseases
by: N. V. Gonchar, et al.
Published: (2022-07-01) -
Phage DisCo: targeted discovery of bacteriophages by co-culture
by: Eleanor A. Rand, et al.
Published: (2025-06-01)